Enclosed herewith is the announcement under Regulation 30 of SEBI (LODR) Regulations, 2015. Kindly take the same on record.

November 02, 2026 BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited Dalal Street, Exchange Plaza, Plot no. C/1, G Block, Mumbai- 400 001 Bandra-Kurla Complex Scrip Code: 543434 Bandra (E), Mumbai - 400 051 NSE Symbol: SUPRIYA Dear Sir/Madam, Subject: Further Update on Judicial Proceedings – Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation to the earlier intimations made by the Company in relation to the captioned matter, we wish to inform you that Mr. Sreekant Sreedharan, General Manager – Sales & Marketing of the Company, has been granted bail from the sessions court in the matter of the judicial proceedings under the Narcotic Drugs and Psychotropic Substances Act, 1985, subject to conditions mentioned in the order passed by the Hon’able Court on November 2, 2026. The Company shall continue to keep the Stock Exchanges and its stakeholders informed of any further material developments in the matter, as and when the same arise. Kindly take the above information on record. Thanking you, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE Annexure as required under Regulation 30 read with Schedule III of SEBI LODR Particulars Details Name of the Hon'ble Session Court authority Nature and Order dated November 02, 2026, allowing bail to Mr. Sreekant Sreedharan, General Manager details of the – Sales & Marketing of the Company, subject to conditions mentioned. order Date of receipt November 02, 2026 of order Mr. Sreekant Sreedharan, General Manager – Sales & Marketing of the Company, has been Details of the granted bail from the sessions court in the matter of judicial proceedings under the Narcotic matter Drugs and Psychotropic Substances Act, 1985, subject to conditions mentioned in the order passed by the Hon’able Court on November 2, 2026. Impact on the The order does not have Material impact on the Company. listed entity Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE